4 completed, 2 unknown, 1 withdrawn. 7 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 4, Unknown 2, Withdrawn 1 |
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow Vestibular Diseases: new trials by email Literature Review of Vestibular Diseases trials Research Report on Vestibular Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease APSLXR - Meniere Disease, Vertigo | Phase 1 | Withdrawn | Apsen Farmaceutica S.A. | 2023-01-01 | 2026-09-08 | |
| Automated Robotic Maneuvering System (RMS) vs Manual Reposition Maneuver in Treatment of Benign Paroxysmal Positional Vertigo (BPPV) Automated vertigo repositioning chair, Canalith Reposition Maneuver - Benign Paroxysmal Positional Vertigo | Phase 1 / Phase 2 | Completed | Stratejik Yenilikci Girisimler Ltd. | 75 | 2022-02-15 | 2022-04-29 |
| Evaluation of the Efficacy of Vertistop® D and Vertistop® L in the Prevention of BPPV Recurrence Vertistop® D - Benign Paroxysmal Positional Vertigo, Vitamin D | Phase 1 | Completed | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 126 | 2018-11-01 | 2023-02-28 |
| Study to Evaluate SPI-1005 in Adults With Meniere's Disease SPI-1005 - Meniere's Disease | Phase 1 / Phase 2 | Completed | Sound Pharmaceuticals, Incorporated | 40 | 2015-12-01 | 2026-06-29 |
| OTO-104 for Meniere's Disease OTO-104 (steroid) 3 mg, Placebo, OTO-104 (steroid) 12 mg - Meniere's Disease | Phase 1 | Completed | Otonomy, Inc. | 44 | 2010-03-01 | 2011-06-08 |
| Visual Feedback Goggle for Positional Vertigo Treatment Goggle with 20 degree error, Optimized Goggle - Positional Vertigo, Vertigo | Phase 1 / Phase 2 | Unknown | Vertigone Inc. | 60 | 2006-11-01 | 2008-08-08 |
| Use of a Vibrotactile Sensory Prosthesis in Patients With Postural Imbalance and Spatial Disorientation Vibrotactile feedback - Vestibular Diseases, Peripheral Neuropathies | Phase 1 | Unknown | Imperial College London | 30 | 2005-01-01 | 2016-11-11 |
Vertigo (5) · Benign Paroxysmal Positional Vertigo (3) · Meniere Disease (3) · Hearing Loss (2) · Tinnitus (2) · Dizziness (1) · Perceptual Disorders (1) · Peripheral Nervous System Diseases (1) · Somatosensory Disorders (1)
Ear Diseases (7) · Labyrinth Diseases (7) · Nervous System Diseases (7) · Neurologic Manifestations (7) · Otorhinolaryngologic Diseases (7) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Sensation Disorders (4) · Endolymphatic Hydrops (3) · Hearing Disorders (2) · Neurobehavioral Manifestations (1) · Neuromuscular Diseases (1) · Vertigo (1)
Eye Protective Devices (1) · Steroids (1) · ebselen (1)
Apsen Farmaceutica S.A. (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Imperial College London (1) · Otonomy, Inc. (1) · Sound Pharmaceuticals, Incorporated (1) · Stratejik Yenilikci Girisimler Ltd. (1) · Vertigone Inc. (1)
United States (3) · Italy (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Adolfo M Bronstein, Pr, MD (1) · Carl LeBel, PhD (1) · Christopher Kennard, Pr, MD (1) · Jonathan Kil, MD (1) · Masud Husain, Dr (1) · Michael A Gresty, Pr (1) · Murat H Ozkul, M.D. (1) · Pasqualina M Picciotti (1) · Philip F Anthony, MD (1)
PMID 17135456, PMID 23245911, PMID 24381922, PMID 27174206, PMID 27757201, PMID 28248609, PMID 31256095, PMID 32483557, PMID 34166965, PMID 7816450